Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2050 - External Validation of a Spine SBRT Pain Flare Risk Stratification Model: A Foundation for aFuture Alliance Trial
Speaker: Dibs, Khaled, MD - Ohio State University Wexner Medical Center, Columbus, OH
3:00 PM - 4:00 PM ET

2051 - Preoperative Circulating Cell-Free DNA as a Prognostic Biomarker in Surgically Treated Spinal Metastatic Disease
Speaker: Dibs, Khaled, MD - Ohio State University Wexner Medical Center, Columbus, OH
3:00 PM - 4:00 PM ET

2052 - Dosimetric Tolerances of the Brainstem and Anterior Optic Pathway to Re-Irradiation In Recurrent Gliomas
Speaker: Djavadian, Reza, MD, PhD - University of Alabama at Birmingham, Birmingham, AL
3:00 PM - 4:00 PM ET

2053 - Treatment Pathway, Not Histology, Determines Survival in a 10-Year Radical-Intent Oesophageal Cancer Cohort
Speaker: Dobeson, Caroline - The Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne
3:00 PM - 4:00 PM ET

2054 - Stereotactic Body Radiotherapy after Whipple Resection: Feasibility, Toxicity and Local Control
Speaker: Ebrahimi, Sasha, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA
3:00 PM - 4:00 PM ET

2055 - Evaluation of Meningioma With 64Cu-DOTATATE PET: Initial Single-Institution Experience
Speaker: Elangovan, Vignesh, BS - Department of Radiation Oncology, The University of Pittsburgh, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2056 - Impact of Complete GTV Inclusion within =110% Isodose on Local Control and Toxicity after Spine Reirradiation SBRT
Speaker: Elguindy, Ahmed, MD - James Cancer Hospital-Solove Research Institute, Columbus, OH
3:00 PM - 4:00 PM ET

2057 - Discrepancies In Pancreatic Cancer Genomic Landscape between the Cancer Genome Atlas and a Large Single-Institution Database
Speaker: Ellsworth, Susannah, MD - University of Pittsburgh Cancer Centers, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2058 - Stereotactic Body Radiotherapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)- Prospective Study
Speaker: Engineer, Reena, MD - Tata Memorial Centre, Mumbai, Please Select
3:00 PM - 4:00 PM ET

2059 - Hypofractionated FLASH Carbon Ion Radiotherapy Outperforms Standard Dose-Rate Treatment in Genetically Engineered Pancreatic Cancer Models: Impact of Adaptive Immune Responses
Speaker: Eskandarian, Saleh, MS, MPE - German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurt
3:00 PM - 4:00 PM ET

2060 - Efficacy of Chemoradiotherapy Combined with Camrelizumab in Patients with Oligometastatic Esophageal Squamous Cell Carcinoma Who Previously Received Definitive Treatment: Preliminary Results of a Phase II Trail
Speaker: Fan, ChengCheng, MD - Henan Cancer Hospital, Zhengzhou, HeNan
3:00 PM - 4:00 PM ET

2061 - Effect of Combined Deep Hyperthermia Therapy on Radiation Proctitis in Patients with Rectal Cancer Receiving Neoadjuvant Chemoradiotherapy: A Single-Center Case-Control Study
Speaker: Fan, Chunbo - chongqing uninersity cancer hospital, chongqing, chongqing